| Home Forums |
|
|||||||
| Clinical Trials Considering or participating in research studies |
 |
|
|
Thread Tools | Search this Thread |
|
#1
Mon Jan 23, 2017, 04:54 PM
|
|||
|
|||
|
Trial on rigosertib
My 75 year old husband is being considered for a trial on rigosertib. We are weighing the pluses and minuses. Has anyone gone through this trial . What is your experience on it . Thank you
|
|
#2
Mon Jan 23, 2017, 08:42 PM
|
|||
|
|||
|
Since Vidaza didn't help your husband, it sounds like he's a prime candidate for the new rigosertib Phase 3 trial, which is currently recruiting patients.
This trial is unusual in that it stemmed from a previous trial that was unsuccessful overall in extending MDS patient survival (comparing rigosertib treatment to standard care). However, statistics from that study showed that rigosertib helped survival for patients who had no response to Vidaza (or another hypomethylating agent). With the new study, researchers will study this effect for high-risk MDS patients. It's strange to think that having no response to Vidaza may actually be better for a patient than having a partial response or a response and relapse, if rigosertib is available to them.
|
|
| Thread Tools | Search this Thread |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Participating In VIDAZA Oral Drug Clinical Trial | nurseAngie | Clinical Trials | 3 | Sun Dec 28, 2014 04:31 PM |
| More results from trials with T-cells | Birgitta-A | Clinical Trials | 11 | Wed Dec 18, 2013 11:58 PM |
| Curcumin/Gingerol Clinical Trial for MDS | Janice M. | Clinical Trials | 13 | Mon May 13, 2013 11:03 AM |
| Clinical Trial of Oral Rigosertib (Estybon) | Samantha R. | Clinical Trials | 5 | Mon Jun 25, 2012 05:00 PM |
| Phase 1 Dacogen Trial | Jordan | Clinical Trials | 1 | Mon Mar 10, 2008 05:08 PM |
